Transplantation-related toxicities/relapse
| Toxicity . | Related donor . | Unrelated donor . | CB . | Overall, no. (%) . | ||
|---|---|---|---|---|---|---|
| BM . | PBSCs . | BM . | PBSCs . | |||
| N | 8 | 8 | 10 | 9 | 12 | 47 |
| Acute GVHD | ||||||
| No. evaluable | 7 | 8 | 8 | 9 | 9 | 41 |
| No. with acute GVHD, grades 1 or 2 | 1 | 1 | 2 | 5 | 2 | 11 (27) |
| No. with acute GVHD, grades 3 or 4 | 0 | 0 | 1 | 0 | 0 | 1 (2) |
| No. with no acute GVHD | 6 | 7 | 5 | 4 | 7 | 29 (71) |
| Chronic GVHD | ||||||
| No. evaluable | 5 | 7 | 6 | 7 | 6 | 31 |
| No. with chronic GVHD | 2 | 3 | 1 | 2 | 0 | 8 (26) |
| No. with no chronic GVHD | 3 | 4 | 5 | 5 | 6 | 23 (74) |
| Other events | ||||||
| No. (%) with transplantation-related mortality | 0 | 0 | 3 (30) | 2 (22) | 1 (8) | 6 (13) |
| No. (%) with relapse | 4 (50) | 5 (63) | 3 (30) | 4 (44) | 5 (42) | 21 (45) |
| Toxicity . | Related donor . | Unrelated donor . | CB . | Overall, no. (%) . | ||
|---|---|---|---|---|---|---|
| BM . | PBSCs . | BM . | PBSCs . | |||
| N | 8 | 8 | 10 | 9 | 12 | 47 |
| Acute GVHD | ||||||
| No. evaluable | 7 | 8 | 8 | 9 | 9 | 41 |
| No. with acute GVHD, grades 1 or 2 | 1 | 1 | 2 | 5 | 2 | 11 (27) |
| No. with acute GVHD, grades 3 or 4 | 0 | 0 | 1 | 0 | 0 | 1 (2) |
| No. with no acute GVHD | 6 | 7 | 5 | 4 | 7 | 29 (71) |
| Chronic GVHD | ||||||
| No. evaluable | 5 | 7 | 6 | 7 | 6 | 31 |
| No. with chronic GVHD | 2 | 3 | 1 | 2 | 0 | 8 (26) |
| No. with no chronic GVHD | 3 | 4 | 5 | 5 | 6 | 23 (74) |
| Other events | ||||||
| No. (%) with transplantation-related mortality | 0 | 0 | 3 (30) | 2 (22) | 1 (8) | 6 (13) |
| No. (%) with relapse | 4 (50) | 5 (63) | 3 (30) | 4 (44) | 5 (42) | 21 (45) |